Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Equity Lifestyle Properties
ELS
$12.7B
| $13.5M | 0.01% |
172,725
+20,800
| +14% | +$1.7M |
|
1677
Tetra Tech
TTEK
$8.42B
| $13.5M | 0.01% |
451,660
+109,765
| +32% | +$3.01M |
|
1678
Zillow
ZG
$7.79B
| $13.5M | 0.01% |
151,985
+131,940
| +658% | +$13.5M |
|
|
VMW
1679
DELISTED
VMware, Inc
VMW
| $13.4M | 0.01% |
90,309
+44,662
| +98% | +$6.77M |
|
|
SNBR
1680
DELISTED
Sleep Number
SNBR
| $13.4M | 0.01% |
143,583
+24,741
| +21% | +$2.45M |
|
|
VNE
1681
DELISTED
Veoneer, Inc.
VNE
| $13.4M | 0.01% |
393,977
+345,142
| +707% | +$11M |
|
1682
CALL
Altria Group
MO
$113B
| $13.4M | 0.01% |
293,900
+162,600
| +124% | +$7.85M |
|
1683
CALL
GSK
GSK
$104B
| $13.4M | 0.01% |
+280,000
| New | +$14.1M |
|
|
MBT
1684
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $13.4M | 0.01% |
1,387,095
+652,105
| +89% | +$5.87M |
|
|
IPVI
1685
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
| $13.4M | 0.01% |
1,379,283
+1,000,000
| +264% | +$9.75M |
|
1686
Dr. Reddy's Laboratories
RDY
$9.85B
| $13.4M | 0.01% |
1,025,805
+775,690
| +310% | +$10.3M |
|
|
DNAB
1687
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $13.4M | 0.01% |
1,352,399
-212,172
| -14% | -$2.09M |
|
|
APLS
1688
DELISTED
Apellis Pharmaceuticals
APLS
| $13.4M | 0.01% |
+405,382
| New | +$22.8M |
|
1689
CALL
Petrobras
PBR
$123B
| $13.3M | 0.01% |
1,291,100
| – | – |
|
1690
Albemarle
ALB
$13.9B
| $13.3M | 0.01% |
60,946
+42,306
| +227% | +$9.04M |
|
|
CTAQ
1691
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
| $13.3M | 0.01% |
1,365,533
| – | – |
|
1692
SITE Centers
SITC
$227M
| $13.3M | 0.01% |
1,106,858
-251,856
| -19% | -$3.05M |
|
1693
Prestige Consumer Healthcare
PBH
$2.37B
| $13.3M | 0.01% |
237,243
+203,276
| +598% | +$11.2M |
|
|
ATCO
1694
DELISTED
Atlas Corp.
ATCO
| $13.3M | 0.01% |
874,764
+433,643
| +98% | +$6.2M |
|
|
PARA
1695
CALL
DELISTED
Paramount Global Class B
PARA
| $13.3M | 0.01% |
336,100
-221,900
| -40% | -$9.04M |
|
1696
BellRing Brands
BRBR
$1.53B
| $13.3M | 0.01% |
431,274
-167,061
| -28% | -$5.35M |
|
1697
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $13.2M | 0.01% |
262,930
-176,573
| -40% | -$9.19M |
|
1698
First Merchants
FRME
$2.69B
| $13.2M | 0.01% |
316,571
+134,674
| +74% | +$5.48M |
|
1699
Extreme Networks
EXTR
$3.9B
| $13.2M | 0.01% |
1,344,549
+59,492
| +5% | +$628K |
|
1700
iShares MSCI Australia ETF
EWA
$1.41B
| $13.2M | 0.01% |
533,450
+130,706
| +32% | +$3.38M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.